Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
ACRobat: Piclidenoson vs Methotrexate in Early RA
NCT02647762Phase 3Terminated
- Sponsor
- Can-Fite BioPharma Ltd.
- Start
- Oct 2017
- Primary completion
- Nov 2020
- Modality
- Small Molecules
- Countries
- 7
01
Overview
A Phase 3 trial of piclidenoson in rheumatoid arthritis (RA), sponsored by Can-Fite BioPharma Ltd.. Started Oct 2017; status: terminated.
02
Drugs
piclidenoson
03
Conditions
rheumatoid arthritis (RA)
Beyond the preview
Go deeper on NCT02647762.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02647762.